IVEMEND subst sèche 150 mg flac
7680579130037
CH-57913
A04AD12
01.09.0.
Reimbursement limitations:
IVEMEND2
Administration intraveineuse d’une dose unique pour le traitement des vomissements dus à une chimiothérapie avec …
1 / 3
google
Details
- Product number
- 5791302
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: fosaprepitantum 150 mg ut dimeglumini fosaprepitantum, dinatrii edetas, polysorbatum 80, lactosum, pro vitro.
Articles (1)
Ivemend 150 mg, Infusionspräparat
Infusionspräparat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | WIZUS |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
1.89 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 79.75
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2014
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 57913
- Drug name
- Ivemend, Pulver zur Herstellung einer Infusionslösung
- Galenic form
- PULVI
- ATC Code
- A04AD12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 03/07/2008
- Authorization expiration date
- 31/12/9999
- IT number
- 01.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IVEMEND subst seche 150 mg 1 pce
- Description (DE)
- IVEMEND Trockensub 150 mg 1 Stk
- Market launch
- 14/03/2011
- Narcotic (BTM)
- No